Innodata (INOD) AI Stock Analysis

Compare

2,456 Followers

Top Page

Innodata

(NASDAQ:INOD)

Select Model

Outperform 71 (OpenAI - 5.2)

Rating:71Outperform

Price Target:

$49.00

▲(10.94% Upside)

Action:UpgradedDate:02/28/26

The score is driven primarily by improving financial performance (profitability/cash flow turnaround and a conservative balance sheet) and a constructive earnings-call outlook (strong FY2025 results and ~35% 2026 growth guidance). Offsetting these positives are weak technical momentum (below key moving averages with negative MACD) and a high valuation multiple that increases sensitivity to execution and near-term run-rate variability.

Positive Factors

Sustained Revenue Growth

A clear multi-year growth trajectory (FY2025 +48% and guidance ~35% for 2026) signals durable demand for Innodata's AI data services. Sustained top-line expansion supports scale economics, larger multi‑year contracts and continued reinvestment into platform and talent, strengthening repeatable revenue streams.

Improved and Healthy Margins

High gross margins (~42%) and meaningful adjusted EBITDA (22%) reflect pricing power and operational leverage in data engineering services. Sustained margin levels imply ability to absorb reinvestment while generating profits, supporting cash flow and funding longer-term R&D and platform improvements.

Strong Balance Sheet & Cash Generation

Material cash reserves, an undrawn credit line and low leverage give the company durable financial flexibility to fund R&D, scale delivery teams, absorb client timing variability, and pursue strategic investments or M&A without pressuring operating liquidity in the medium term.

Negative Factors

TTM Revenue Inconsistency

A sharp divergence between annual results and TTM figures signals inconsistency in revenue recognition or client activity. Persistent volatility undermines confidence in sustaining current margins and makes future operating results and cash generation sensitive to renewal timing and project cadence.

Client Concentration & Workflow Deprecation

Losing or replatforming ~$20M of run-rate work from the largest client highlights concentration risk. Dependence on a single large customer amplifies revenue and timing exposure, forcing costly re‑platforming and creating uncertainty about net-net retention versus replacement revenue.

Early‑Stage Initiatives & Execution Risk

Key growth initiatives (agent services, adversarial testing, robotics datasets) being early-stage means meaningful revenue and margin upside depend on successful scaling. Execution delays or slower adoption would compress near-term margins and make forecasted growth and margin targets harder to realize.

Innodata (INOD) vs. SPDR S&P 500 ETF (SPY)

Market Cap

$1.44B

Dividend YieldN/A

Average Volume (3M)1.36M

Price to Earnings (P/E)48.4

Beta (1Y)3.73

Revenue Growth73.57%

EPS Growth56.21%

CountryUS

Employees6,597

SectorTechnology

Sector Strength88

IndustryInformation Technology Services

Share Statistics

EPS (TTM)0.25

Shares Outstanding32,602,398

10 Day Avg. Volume866,868

30 Day Avg. Volume1,355,736

Financial Highlights & Ratios

PEG Ratio16.45

Price to Book (P/B)15.14

Price to Sales (P/S)6438.48

P/FCF Ratio45.46

Enterprise Value/Market Cap0.93

Enterprise Value/Revenue5.32K

Enterprise Value/Gross Profit13.46K

Enterprise Value/Ebitda230.65

Forecast

1Y Price Target

$96.67

Price Target Upside118.86% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering3

EPS Forecast (FY)1.12

Revenue Forecast (FY)$313.21M

Innodata Business Overview & Revenue Model

Company DescriptionInnodata Inc. operates as a global data engineering company in the United States, the United Kingdom, the Netherlands, Canada, and internationally. The company operates through three segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment offers AI-enabled software platforms and managed services to companies that require data for training AI and machine learning (ML) algorithms, and AI digital transformation solutions to help companies apply AI/ML for problems relating to analyzing and deriving insights from documents. This segment provides a range of data engineering support services, including data annotation, data transformation, data transformation, data curation, data hygiene, data consolidation, data compliance, and master data management. The Synodex segment offers an industry platform that transforms medical records into useable digital data with its proprietary data models or client data models. The Agility segment provides an industry platform that provides marketing communications and public relations professionals to target and distribute content to journalists and social media influencers; and to monitor and analyze global news channels, such as print, web, radio, and TV, as well as social media channels. It serves banking, insurance, financial services, technology, digital retailing, and information/media sectors through its professional staff, senior management, and direct sales personnel. The company was formerly known as Innodata Isogen, Inc. and changed its name to Innodata Inc. in June 2012. Innodata Inc. was incorporated in 1988 and is headquartered in Ridgefield Park, New Jersey.

How the Company Makes MoneyInnodata generates revenue through a combination of service contracts, project-based work, and subscription models. Key revenue streams include the provision of data management and analytics services, where clients pay for customized solutions that address specific business needs. The company also earns income from licensing proprietary technologies and tools that facilitate data processing and content management. Significant partnerships with major corporations in the publishing and media sectors further bolster its revenue, as these collaborations often lead to long-term contracts and recurring revenue. Additionally, the increasing demand for digital transformation services in various industries contributes to Innodata's earnings, as organizations seek to optimize their data usage and improve operational workflows.

Innodata Key Performance Indicators (KPIs)

Any

Adjusted EBITDA by Segment

Adjusted EBITDA by Segment
Provides a view of operating performance by segment, excluding non-cash items and one-time charges, to assess underlying profitability and cash flow potential.

Chart InsightsInnodata's DDS segment shows a dramatic surge in adjusted EBITDA, reflecting the company's strategic focus on generative AI and Agentic AI, which aligns with market demands. This growth is bolstered by significant new deals and a robust pipeline, as highlighted in the earnings call. Synodex and Agility segments also show positive momentum, contributing to the overall 375% increase in adjusted EBITDA. However, increased operating expenses and a higher future tax rate could pose challenges to net income. The company remains optimistic, raising its full-year revenue growth guidance to at least 45%.

Data provided by:

The Fly

Innodata Earnings Call Summary

Earnings Call Date:Feb 26, 2026

(Q4-2025)

% Change Since: |

Next Earnings Date:May 07, 2026

Earnings Call Sentiment Positive

The call emphasized strong fiscal 2025 results (robust revenue growth, expanded margins, healthy cash build) and showcased multiple technical and commercial innovations with clear potential to drive further growth and margin expansion. Management also acknowledged short-term execution and timing risks — including depreciation of legacy workflows (~$20M run rate), dependence on a largest customer, and several initiatives that remain early-stage — and noted near-term margin normalization due to reinvestment. On balance, the positives (strong growth, profitability, cash position, measurable technical improvements and a constructive 2026 outlook) outweigh the highlighted risks.

Q4-2025 Updates

Positive Updates

Strong Top-Line Growth

Q4 revenue of $72.4M, up 22% year-over-year; FY2025 revenue of $251.7M, up 48% year-over-year; Q4 sequential revenue growth of 15.7% vs Q3 ($62.6M).

Healthy Profitability and Margins

Q4 adjusted gross margin of 42% (above external 40% target); Q4 adjusted gross profit $30.1M (+6% YoY, +9% sequential); adjusted EBITDA $15.7M (22% of revenue), exceeding analyst consensus by $1.2M; Q4 net income $8.8M.

Strong Balance Sheet and Liquidity

Cash balance of $82.2M at year-end (up ~$8.4M sequentially and from $46.9M at year-end 2024 — ~75% year-over-year increase); did not draw on $30M credit facility.

Conservative but Ambitious 2026 Outlook

Company currently forecasts ~35% year-over-year revenue growth for 2026 with potential for significant upside based on active programs, recently awarded wins and late-stage evaluations.

Investments Driving Innovation and Competitive Position

Meaningful growth-oriented investments in COGS and SG&A (engineers, data scientists, customer-facing leadership) aimed at scaling capabilities across generative AI training, agentic AI and physical AI; management expects these to be margin-enhancing over time.

Demonstrable Technical Wins

Developed a drone/small-object detection model that exceeds prior state-of-the-art benchmarks by 6.45%, and built data engineering systems for egocentric and affordance datasets used in robotics engagements (incl. work with Palantir).

Agent & Adversarial Capabilities with Measurable Impact

Agent optimization pipeline showed improvements up to 25 points in constraint satisfaction and in demanding scenarios a >31-point advantage versus standard approaches; adversarial simulation system for robust stress-testing is in early engagements with hyperscalers and security teams.

Expanding Customer Traction and Diversification

Management reports broadening demand across Mag 7, domestic AI innovation labs, sovereign AI initiatives and enterprises; expects other-customer aggregate growth to outpace the largest customer and meaningful revenue diversification in 2026.

Negative Updates

Deprecation of Legacy Workflows (~$20M Run Rate)

Company deprecated post-training workflows representing ~ $20M of annualized revenue run rate for its largest customer; while replaced by new pretraining and post-training programs with a net positive effect, this highlights revenue churn and the need to re-platform workstreams.

Concentration Risk and Timing Variability

Management acknowledges continued material exposure to its largest customer and notes that timing variability in customer ramp schedules, budget approvals or shifts in research priorities could influence the pace at which 2026 revenue materializes.

Near-Term Margin Normalization and Reinvestment

Management expects early-2026 adjusted gross margins in the 35%–40% range before normalizing toward a 40%+ target as new programs ramp; company is actively reinvesting in COGS and SG&A which may compress near-term margins despite long-term upside.

Many Initiatives Still Early-Stage

Several strategic capabilities and engagements (agent optimization managed services, adversarial testing engagements, robotics foundational datasets) are described as early-stage or 'kicking off soon,' creating execution and timing risk for revenue realization.

Forecast Uncertainty Despite Upside

While management guided conservatively to ~35% growth for 2026, it emphasized uncertainty and potential upside, signaling that guidance could be raised but is subject to visibility and deal timing — reflecting residual forecast risk.

Company Guidance

Management guided 2026 revenue growth of approximately 35% year‑over‑year (and said there could be significant upside), building on FY2025 revenue of $251.7M (+48% YoY) and Q4 revenue of $72.4M (+22% YoY, +15.7% sequential from $62.6M); Q4 adjusted gross profit was $30.1M (adjusted gross margin 42%, above the 40% target), Q4 adjusted EBITDA was $15.7M (22% of revenue; beat analyst consensus by $1.2M), Q4 net income was $8.8M, and cash totaled $82.2M (up from $73.9M QoQ and $46.9M YoY) with the $30M Wells Fargo facility undrawn; management expects early‑2026 adjusted gross margins of 35–40% with normalization toward ≥40% as new programs scale.

Innodata Financial Statement Overview

Summary

Financials reflect a clear turnaround with strong 2024 profitability and improved operating/free cash flow alongside low leverage. The key risk is inconsistency: TTM revenue is described as sharply lower than the prior year and TTM margins appear unusually extreme, raising sustainability and run-rate concerns.

Income Statement

Positive

Annual results show a strong profitability inflection: revenue nearly doubled in 2024 and the company moved from losses in 2022–2023 to solid profits in 2024 with healthy gross margins. However, the TTM (Trailing-Twelve-Months) revenue figure is dramatically lower than the prior year (a sharp decline), and the TTM profit margins appear unusually extreme versus historical levels, which raises questions about sustainability and consistency versus the annual run-rate.

Balance Sheet

Very Positive

The balance sheet is conservatively positioned with low leverage (debt-to-equity remains modest) and equity building meaningfully over time, supporting financial flexibility. Returns on equity are strong in 2024 and TTM, but the company had negative returns during the loss years (2021–2023), highlighting that profitability has been volatile even if leverage is currently well controlled.

Cash Flow

Positive

Cash generation improved materially versus the loss years: operating cash flow and free cash flow were strong in 2024 and remained solid in TTM (Trailing-Twelve-Months). Free cash flow conversion is decent but not perfect (free cash flow trails net income), and TTM free cash flow declined versus 2024, suggesting some recent softening despite an overall much stronger cash profile than 2021–2023.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	251.70K	170.46M	86.78M	79.00M	69.75M
Gross Profit	99.50K	66.93M	31.91M	27.66M	26.26M
EBITDA	6.93M	30.28M	5.03M	-6.59M	1.22M
Net Income	32.18M	28.66M	-908.00K	-11.94M	-1.67M
Balance Sheet
Total Assets	168.59M	113.45M	59.43M	48.04M	59.22M
Cash, Cash Equivalents and Short-Term Investments	82.23M	46.90M	13.82M	10.30M	18.90M
Total Debt	13.71M	4.66M	5.48M	4.73M	6.31M
Total Liabilities	61.53M	50.06M	34.44M	30.00M	32.81M
Stockholders Equity	107.06M	63.47M	25.70M	18.77M	29.93M
Cash Flow
Free Cash Flow	35.65M	27.27M	339.00K	-7.74M	783.00K
Operating Cash Flow	46.75M	35.02M	5.90M	-1.22M	5.15M
Investing Cash Flow	-11.10M	-7.74M	-5.07M	-7.03M	-4.37M
Financing Cash Flow	-426.00K	6.06M	2.87M	-307.00K	773.00K

Innodata Technical Analysis

Technical Analysis Sentiment

Negative

Last Price44.17

Price Trends

50DMA

53.26

Negative

100DMA

60.15

Negative

200DMA

54.53

Negative

Market Momentum

MACD

-2.84

Negative

RSI

40.73

Neutral

STOCH

76.46

Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For INOD, the sentiment is Negative. The current price of 44.17 is below the 20-day moving average (MA) of 46.83, below the 50-day MA of 53.26, and below the 200-day MA of 54.53, indicating a bearish trend. The MACD of -2.84 indicates Negative momentum. The RSI at 40.73 is Neutral, neither overbought nor oversold. The STOCH value of 76.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for INOD.

Innodata Risk Analysis

Innodata disclosed 14 risk factors in its most recent earnings report. Innodata reported the most risks in the "Legal & Regulatory" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added 0 New Risks

Innodata Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
INOD	71 Outperform	$1.44B	48.38	46.40%	―	73.57%	56.21%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
ASGN	61 Neutral	$1.77B	16.47	6.34%	―	-4.86%	-25.15%
GLOB	61 Neutral	$2.19B	21.37	4.91%	―	5.56%	-42.38%
APX	61 Neutral	AU$499.86M	-14.35	-24.40%	―	-9.02%	80.67%
AI	47 Neutral	$1.12B	-2.52	-55.01%	―	1.84%	-27.74%
BBAI	46 Neutral	$1.73B	-2.79	-111.83%	―	-6.95%	-53.69%

* Technology Sector Average

Performance Comparison

INOD

Innodata

44.17

-6.59

-12.98%

ASGN

42.90

-22.20

-34.10%

GLOB

Globant SA

49.76

-93.80

-65.34%

AU:APX

Appen

1.87

0.48

34.66%

C3ai

7.95

-14.08

-63.91%

BBAI

BigBearai Holdings

3.96

-0.80

-16.81%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 28, 2026